Difficult to obtain antibody drugs are now available as research consumables
Advantages of Drug Aliquots
Reference drugs ordered in 5 min
Therapeutic drugs as aliquots
Multiple drug batches
Consumable = no license needed
Prompt Delivery
Research use only
Price: Fraction of original drug
What our clients say
Anjan Selz
Vice President
Head of Biosimilars EMEA
”Evidentic can supply different batches of reference products for precilinical research.The quick access to the on-stock batches allows for adhoc ordering, keeps costs down and makes a headstart possible!”
Thibault Jonckheere
CEO
“Evidentic is a new source of cost-efficient therapeutic mAbs for our immonassays. And easy to order!”
Tom H. Jin, M.D.
Director of Process Development
“We develop innovative and biosimilar mAbs for a global market. Evidentic’s aRMPs are a great source of cost-efficient reference products for our research and development program.”
Prof. Dr. Henning von Horsten
Life Science Engineering, HTW Berlin
“Evidentic gives rapid access to originator biologics and different batches. For biosimilar developers and regulators, it will shorten the time to gauge the analytical acceptance range for multiple CQAs of biotherapeutics.”
Dr Stephan Schultz
Team Leader of Analytics/DSP
“Evidentic drug aliquots have significantly reduced our development cycle time and strengthened our ability to do detailed [protein] characterization”
Easy Access
Easy to order as license-free research consumable
Multiple batches
Up to 10 batches of original drugs for examining batch-to-batch variations
Reduce costs
Up to 80% less compared to the original pharmaceutical price
Prompt delivery
Shipment within days worldwide according to GDP-standards
